Objective:

To present long-term evidence on the effectiveness of MiYOSMART spectacle lenses in controlling myopia progression in children.

Key Findings:

• MiYOSMART lenses slowed myopia progression by 59% and reduced axial elongation by 60% on average.
• Children wearing MiYOSMART lenses for eight years showed significantly less myopia progression (-0.44 ± 0.64D) compared to those with shorter wear durations (-1.44 ± 1.31D).
• No adverse events or rebound effects were reported after discontinuation of treatment.

Interpretation:

The 8-year data confirms that consistent use of MiYOSMART lenses provides sustained myopia control, essential for informed clinical decision-making and parental reassurance.

Limitations:

• MiYOSMART lenses are not approved for use in all countries, including the US.
• The study may not represent all demographics as it focuses on specific populations.

Conclusion:

Long-term evidence supports the use of MiYOSMART lenses as a standard of care for managing myopia in children, emphasizing the need for access to evidence-based interventions.